It has been a busy day for CEPI2 Jun 2021 17:19
'Our CEO
@DrRHatchett
spoke today at
@gavi
's #COVAX AMC Summit on the need to advance global access to doses'
"To end the acute phase of the pandemic as quickly as possible we must empower COVAX to deliver to its full potential. If we don’t, we will leave billions behind."
"The value of vaccines in breaking chains of transmission, preventing hospitalization and saving lives in countries that have access to them is now indisputable.
"This is the result of a staggering global scientific effort, the success of which has surpassed all of our expectations."
"At CEPI, as the lead COVAX partner for R&D, we’re funding additional vaccine candidates through late stage clinical trials..."
"...including vaccines targeting variants of concern, which we’re hopeful will produce hundreds of millions of additional doses for COVAX. We’re also investing in mix-and-match studies, to help us maximize the benefit from every dose of vaccine available."
"But the devastating surge of cases in India is a sobering and terrifying reminder of what this virus is capable of."
"The emergence of new and more transmissible COVID-19 variants makes achieving fair global access to vaccines to protect the most vulnerable."
"COVAX has proven that the mechanism works. What we need now is access to doses. COVAX is working across many domains, and through a new manufacturing taskforce to increase its supply of vaccines, and today we are calling on the global community to help COVAX."
"Our success is only possible thanks to the generosity of our partners and donors, and I thank you in advance for your support."